Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CAN CSA C22.2 No. 61010-2-101-15 – Safety Requirements for In Vitro Diagnostic Medical Equipment
Comprehensive Guide to Canadian Compliance for IVD Equipment Safety
Scope and Application
CAN CSA C22.2 No. 61010-2-101-15 (also referenced as CSA C22.2 No. 61010-2-101-15) applies to in vitro diagnostic (IVD) medical equipment as a particular standard within the IEC 61010 family. It specifically covers electrical equipment for measurement, control, and laboratory use that is intended for the in vitro examination of specimens derived from the human body. This includes instruments such as hematology analyzers, chemistry analyzers, immunoassay analyzers, coagulation instruments, and sample preparation systems.
This standard is the Canadian adoption of IEC 61010-2-101:2015, including national deviations for Canada. It is intended to be used in conjunction with the base standard CAN CSA C22.2 No. 61010-1, which is identical to IEC 61010-1:2010 (Third Edition). The Part 2-101 adds or modifies requirements related to biological hazards, chemical hazards, and handling of infectious materials that are specific to IVD equipment.
The standard does not apply to equipment covered by other product safety standards, such as IEC 60601-1 for medical electrical equipment that may come into direct patient contact, or IEC 61010-2-061 for laboratory atomic spectrometers.
Key Technical Requirements
The standard imposes comprehensive safety requirements across electrical, mechanical, thermal, radiation, and biological domains. The IVD-specific clauses primarily reinforce protections against hazards unique to handling biological specimens and associated reagents.
| Requirement Area | Details | Referenced Clauses |
|---|---|---|
| Risk Management | Manufacturers must establish and maintain a risk management file per ISO 14971. Risks associated with specimen handling, reagent leaks, and software failure must be identified and mitigated. | Clause 4, Annex J |
| Protection against electric shock | Basic and supplementary insulation, creepage and clearance distances, protective earthing, and leakage current limits. National differences for test voltages at 125 V, 250 V, and 600 V ratings. | Clause 5, 6, Annex C (Canadian deviations) |
| Temperature and fire | Maximum accessible surface temperatures (e.g., 95 °C for operator touch surfaces). Equipment with combustible reagents must use flame-resistant enclosures (V-1 minimum). | Clause 7, 9, 10 |
| Biological hazards | Containment of spilled specimens, aerosol prevention, accessible waste containers, and disinfection procedures. Equipment must pass leak‑proofness and autoclavability tests if intended. | Clause 11, Annexes K, L |
| Chemical hazards | Requirements for handling and storage of reagents including flammability and toxicity. Operators must be warned via markings and manuals. | Clause 12 |
| Software safety | Programmable IVD systems must be validated per the software life cycle requirements of IEC 62304. Single‑fault conditions must not lead to hazardous release of specimens. | Clause 14, Annex R |
Implementation Highlights for Manufacturers
Compliance with CAN CSA C22.2 No. 61010-2-101-15 requires a structured approach:
- Use of the Base Standard: All Part 1 requirements of CAN CSA C22.2 No. 61010-1 (IEC 61010-1:2010) apply except where the Part 2-101 modifies them.
- National Deviations: Canada and the USA share many deviations listed in Annex C. These affect test voltages, plug configurations, and wiring colour codes. Manufacturers targeting both markets can often use a single design.
- Risk Management: The standard requires a dedicated risk management report for IVD‑specific hazards (e.g., infection from used needles, chemical spills). This report must be part of the technical documentation submitted for certification.
- Documentation Language: All user manuals, service manuals, and safety messages must be in both English and French. Markings must include the bilingual Canadian requirements.
- Factory Audits: CSA Group certification includes initial product testing plus annual factory inspections to maintain the CSA mark.
Tip: Begin your risk management process early. Many IVD hazards can be designed out at the concept stage, simplifying later compliance with biological and chemical safety clauses.
Compliance and Certification Notes
To obtain CSA certification for IVD equipment under this standard, manufacturers must:
- Determine the full scope of applicable requirements from both Part 1 and Part 2-101.
- Prepare a detailed risk management file that covers the intended use, reasonably foreseeable misuse, and all life‑cycle phases (transport, installation, operation, maintenance, disposal).
- Provide test samples that are representative of production units. Testing includes electrical safety (dielectric strength, leakage), mechanical tests (stability, impact), and IVD‑specific tests (leakage of sample compartments, resistance to cleaning agents).
- Submit technical documentation to a recognized certification body (e.g., CSA Group).
Warning: The transition from older editions may require recertification. CAN CSA C22.2 No. 61010-2-101-15 was reaffirmed in 2020; manufacturers should verify the latest publication status with CSA Group.
Benefit: Compliance with this standard not only satisfies Canadian regulatory requirements but also aligns with international IVD safety expectations, facilitating market access in many regions that adopt the IEC family.
Potential Pitfall: Relying solely on a generic IEC 61010-1 certification without covering IVD‑specific requirements (Clause 11) can result in non‑compliance. CSA‑mark auditors pay close attention to biological hazard controls.
Frequently Asked Questions
Q: What is the relationship between CAN CSA C22.2 No. 61010-2-101-15 and IEC 61010-2-101:2015?
A: The Canadian standard is an identical adoption of the IEC version, with the addition of national deviations for Canada and the USA (Annex C). The technical content is essentially the same, but the Canadian standard includes specific requirements for voltage ratings, wiring, and marking.
A: The Canadian standard is an identical adoption of the IEC version, with the addition of national deviations for Canada and the USA (Annex C). The technical content is essentially the same, but the Canadian standard includes specific requirements for voltage ratings, wiring, and marking.
Q: Does this standard apply to all IVD equipment manufactured for Canada?
A: Yes, for electrical laboratory equipment used in in vitro diagnostics. However, if an IVD device also falls under the scope of IEC 60601-1 (e.g., point‑of‑care analyzers with patient connection), the manufacturer must determine which standard takes precedence. Typically, IEC 60601-1 applies if the device has direct patient contact.
A: Yes, for electrical laboratory equipment used in in vitro diagnostics. However, if an IVD device also falls under the scope of IEC 60601-1 (e.g., point‑of‑care analyzers with patient connection), the manufacturer must determine which standard takes precedence. Typically, IEC 60601-1 applies if the device has direct patient contact.
Q: What are the main differences from the previous edition of the standard?
A: The 2015 edition aligned with the third edition of the base standard (IEC 61010-1:2010), which introduced stronger risk management requirements, stricter creepage and clearance distances, and a new approach for equipment with software and programmable components. The IVD‑specific clauses were updated to reference ISO 14971 and IEC 62304.
A: The 2015 edition aligned with the third edition of the base standard (IEC 61010-1:2010), which introduced stronger risk management requirements, stricter creepage and clearance distances, and a new approach for equipment with software and programmable components. The IVD‑specific clauses were updated to reference ISO 14971 and IEC 62304.
Q: How can a manufacturer ensure smooth compliance?
A: Engage an experienced testing and certification body early in product development. Consider performing a gap analysis between the existing product design and the requirements of the Part 2-101. Pay special attention to biological hazard mitigation, software validation, and bilingual documentation.
A: Engage an experienced testing and certification body early in product development. Consider performing a gap analysis between the existing product design and the requirements of the Part 2-101. Pay special attention to biological hazard mitigation, software validation, and bilingual documentation.
© 2026 CSA Group. This article is provided for informational purposes and does not constitute an official interpretation of the standard.